Side-by-side comparison of AI visibility scores, market position, and capabilities
Danone, parent €27.38B revenue 2024, #1 organic milk brand US, DHA Omega-3 line, 500+ family farms
Horizon Organic is the leading organic dairy brand in the United States, launched in 1991 in Boulder, Colorado, and now owned by Danone, the global food and beverage company headquartered in Paris. Founded on the mission of proving that organic agriculture and commercial-scale dairy production could coexist, Horizon pioneered the mainstream organic milk category and helped establish USDA Organic certification as a trusted consumer signal. The brand's core product philosophy centers on milk free from synthetic pesticides, growth hormones, and antibiotics, sourced from family farms operating under certified organic practices.\n\nHorizon Organic's product portfolio spans organic whole, reduced-fat, and fat-free milk alongside DHA Omega-3 fortified varieties, single-serve milks, and dairy products including butter and cheddar cheese. The brand sources from more than 500 family farms across the United States, emphasizing the pastoral, family-farm imagery that resonates with health-conscious shoppers willing to pay a premium for organic certification. As the number-one organic milk brand in the US, Horizon benefits from first-mover brand equity in a category it helped define and decades of shelf presence in natural and conventional grocery chains alike.\n\nHorizon Organic operates within Danone's North America business, contributing to the parent company's €27.38 billion in global revenue for 2024. Danone has invested in the brand's growth as part of its broader strategy to lead the shift toward plant-based and organic nutrition, positioning Horizon as the anchor brand in its organic dairy portfolio. As consumer demand for clean-label, organic food products continues to grow, Horizon's established brand trust, farm network, and retail distribution give it a durable competitive position in premium dairy.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.